Search Results

Risk factors for psychological distress in oncologists.

• Authors : Robles-García, Rebeca¹ (AUTHOR); Yoldi-Negrete, María² (AUTHOR); Guízar-Sánchez, Diana³ (AUTHOR)

• Source: Psychology, Health & Medicine. Feb2026, p1-13. 13p.

Record details

Impact of Adolescent and Young Adult Cancer Expertise in Oncologists on AYA Outcomes in Hodgkin Lymphoma: A Population‐Based Study in Ontario, Canada.

• Authors : Andrew, Eden C.^1,2 (AUTHOR); Lau, Cindy³ (AUTHOR); Rae, Charlene⁴ (AUTHOR)

• Source: Cancer Medicine. Feb2026, Vol. 15 Issue 2, p1-13. 13p.

Record details

Exploring Oncologists' Perspectives on the Early Integration of Specialty Palliative Care in Korea: Challenges, Needs, and Clinical Implications.

• Authors : Yoo, Shin Hye¹ (AUTHOR); Kim, Yu Jung² (AUTHOR); Jeung, Ye Sul¹ (AUTHOR)

• Source: Cancer Research & Treatment. Jan2026, Vol. 58 Issue 1, p339-348. 10p.

Record details

Could decision aids be helpful during medical consultations? semi-structured interviews with oncologists within the I3LUNG project.

• Authors : Sebri, Valeria¹ (AUTHOR) ; Dorangricchia, Patrizia^1,2 (AUTHOR); Monzani, Dario^1,3 (AUTHOR)

• Source: Cogent Psychology. Dec2025, Vol. 12 Issue 1, p1-10. 10p.

Record details

Diversity and Experiences of Radiation Oncologists in Canada: A Survey of Gender Identity, Sexual Orientation, Disability, Race, Ethnicity, Religion, and Workplace Discrimination-A National Cross-Sectional Electronic Survey.

• Authors : Khan AF; Department of Oncology, University of Calgary, Calgary, AB T2N 4N1, Canada.; Allen S

Subjects: Radiation Oncologists*/Radiation Oncologists*/Radiation Oncologists*/psychology ; Radiation Oncologists*/Radiation Oncologists*/Radiation Oncologists*/statistics & numerical data ; Gender Identity*

• Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2025 Nov 17; Vol. 32 (11). Date of Electronic Publication: 2025 Nov 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729

Record details

The Rs 100 "R+Cu" (resveratrol and copper) anti-cancer magic tablet controversy: Results of online survey among oncologists.

• Authors : Parikh, Purvish M.¹ (AUTHOR) ; Prasad, Narayanan² (AUTHOR); Thirumalairaj, Raja³ (AUTHOR)

• Source: Indian Journal of Cancer. Jul-Sep2025, Vol. 62 Issue 3, p365-371. 7p.

Record details

Burnout among Oncologists in India: Challenges in Outpatient Department Practice and the Way Forward.

• Authors : Ramesh Naga, Supreeth¹ (AUTHOR) ; Akhade, Amol² (AUTHOR)

• Source: Indian Journal of Medical & Paediatric Oncology. Dec2025, Vol. 46 Issue 6, p607-609. 3p.

Record details

History and Development of Clinical Use of Functional Stereotaxy for Radiation Oncologists: From Its Origins to Its Current State.

• Authors : Goulet M; Faculté de Médecine, Université de Montréal, Montreal, QC H3T 1J4, Canada.; Masucci GL

Subjects: Radiosurgery*/Radiosurgery*/Radiosurgery*/methods ; Radiosurgery*/Radiosurgery*/Radiosurgery*/history ; Stereotaxic Techniques*/Stereotaxic Techniques*/Stereotaxic Techniques*/history

• Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2025 Nov 22; Vol. 32 (12). Date of Electronic Publication: 2025 Nov 22.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729

Record details

The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists.

• Authors : Susiriwatananont T; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand.; Jacoby Center for Breast Health, Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.

Subjects: Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/drug effects ; Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/immunology ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use

• Source: Cells [Cells] 2025 Nov 12; Vol. 14 (22). Date of Electronic Publication: 2025 Nov 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

Preferences of Dermato-oncologists for Adjuvant Therapy in Stage II Melanoma: A Nationwide Discrete Choice Experiment.

• Authors : Kraaz A; Department of Dermatology and Phlebology, Vivantes Klinikum im Friedrichshain, Berlin, Germany; Faculty of Medicine, Charité University Medicine Berlin, Germany.

Subjects: Melanoma*/Melanoma*/Melanoma*/pathology ; Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/therapy

• Source: Acta dermato-venereologica [Acta Derm Venereol] 2025 Sep 25; Vol. 105, pp. adv44135. Date of Electronic Publication: 2025 Sep 25.Publisher: MJS Publishing Country of Publication: Sweden NLM ID: 0370310 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-2057

Record details